miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 36, Pages 4284-4293
Publisher
Springer Nature
Online
2012-10-08
DOI
10.1038/onc.2012.433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Drug transporters of platinum-based anticancer agents and their clinical significance
- (2011) Herman Burger et al. DRUG RESISTANCE UPDATES
- Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- miR-200a Regulates Nrf2 Activation by TargetingKeap1mRNA in Breast Cancer Cells
- (2011) Gabriel Eades et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
- (2011) Yukako Imanaka et al. JOURNAL OF HUMAN GENETICS
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB
- (2011) Karen E. Eberle et al. PLoS One
- Suppression of NF-κB signaling by KEAP1 regulation of IKKβ activity through autophagic degradation and inhibition of phosphorylation
- (2010) Jeong-Eun Kim et al. CELLULAR SIGNALLING
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response
- (2009) Joris Pothof et al. EMBO JOURNAL
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
- (2009) Dung-Fang Lee et al. MOLECULAR CELL
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries
- (2009) Stacia K. Wyman et al. PLoS One
- Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients
- (2009) Michael F Gallagher et al. Journal of Ovarian Research
- Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
- (2009) Dawn R. Cochrane et al. Journal of Oncology
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started